Literature DB >> 12998611

[Reserpin, the sedative principle from Rauwolfia serpentina B].

J M MULLER, E SCHLITTLER, H J BEIN.   

Abstract

Entities:  

Keywords:  HYPNOTICS AND SEDATIVES; RAUWOLFIA

Mesh:

Substances:

Year:  1952        PMID: 12998611     DOI: 10.1007/BF02174406

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  1 in total

1.  Chemistry of ajmaline, rauwolfine of Van Itallie and Steenhauer.

Authors:  D MUKHERJI; R ROBINSON; E SCHLITTLER
Journal:  Experientia       Date:  1949-05-15
  1 in total
  26 in total

1.  Clinical uses of rauwolfia. I. In arterial hypertension.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  [Mechanism of action of a new conservative therapy of mitral stenosis with reserpin].

Authors:  H SCHUMANN
Journal:  Klin Wochenschr       Date:  1955-02-01

3.  The complications of reserpine therapy.

Authors:  J G MACARTHUR
Journal:  Postgrad Med J       Date:  1957-11       Impact factor: 2.401

4.  [Cerebral circulation in reserpine treatment of hypertension].

Authors:  A BERNSMEIER; U GOTTSTEIN; W SCHIMMLER
Journal:  Klin Wochenschr       Date:  1957-06-15

5.  Efficacy of ataractic drugs in clinical anaesthesia: a review.

Authors:  A B DOBKIN
Journal:  Can Anaesth Soc J       Date:  1958-04

6.  Notes on Rauwolfia and ancient medical writings of India.

Authors:  K SOMERS
Journal:  Med Hist       Date:  1958-04       Impact factor: 1.419

7.  [Poisoning with reserpine in a small child].

Authors:  F KAYSER
Journal:  Arch Toxikol       Date:  1956

8.  The effects of reserpine on hypertensive patients over a period of two years.

Authors:  R HODGKINSON
Journal:  Br Heart J       Date:  1956-10

9.  Reserpine in peptic ulcer.

Authors:  E J DRENICK
Journal:  Am J Dig Dis       Date:  1956-12

10.  Drug treatment of hypertension.

Authors:  E G MCQUEEN; F H SMIRK
Journal:  Postgrad Med J       Date:  1956-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.